Statement Of Financial Position [Abstract]

Sopharma AD - Filing #6022425

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
357 624 BGN
376 407 BGN
Investment property
11 198 BGN
10 568 BGN
Goodwill
3 439 BGN
3 522 BGN
Intangible assets other than goodwill
57 829 BGN
48 151 BGN
Deferred tax assets
2 818 BGN
2 052 BGN
Cash and cash equivalents
128 879 BGN
19 855 BGN
Assets
1 514 162 BGN
1 253 978 BGN
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
172 591 BGN
134 798 BGN
Retained earnings
395 897 BGN
509 869 BGN
Other equity interest
1 857 BGN
12 488 BGN
Equity attributable to owners of parent
738 332 BGN
704 658 BGN
Non-controlling interests
15 294 BGN
11 976 BGN
Equity
753 626 BGN
395 897 BGN
1 857 BGN
29 328 BGN
15 294 BGN
172 591 BGN
1 154 BGN
57 452 BGN
738 332 BGN
506,000 BGN
196 759 BGN
68 628 BGN
716 634 BGN
35 263 BGN
12 488 BGN
11 976 BGN
509 869 BGN
52 203 BGN
134 798 BGN
4 745 BGN
704 658 BGN
560,000 BGN
50 284 BGN
444 634 BGN
66 201 BGN
36 788 BGN
658 868 BGN
1 644 BGN
12 512 BGN
646 975 BGN
11 893 BGN
682,000 BGN
134 798 BGN
Liabilities [abstract]
Deferred tax liabilities
4 415 BGN
6 397 BGN
Liabilities
760 536 BGN
537 344 BGN
Equity and liabilities
1 514 162 BGN
1 253 978 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.